Valuation Kymera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2026 BST			5-day change	1st Jan Change
84.50 ^USD	-1.27%		-0.15%	+8.60%

12:14pm	Kymera Therapeutics announces presentations on KT-621, a first-in-class, oral Stat6 degrader, at the Society for Investigative Dermatology and American Thoracic Society congresses	RE
05-12	Kymera Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09:20 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	3,259	1,369	1,413	2,606	6,225	6,951	-	-
Change	-	-57.98%	3.16%	84.43%	138.91%	11.66%	-	-
Enterprise Value (EV) ¹	2,819	809.9	976.4	1,755	4,605	5,611	5,747	5,970
Change	-	-71.27%	20.55%	79.7%	162.47%	21.84%	2.42%	3.89%
P/E ratio	-30.4x	-8.7x	-10.1x	-13.5x	-21.1x	-23.7x	-19.4x	-18.4x
PBR	7.12x	2.75x	3.58x	3.61x	4.01x	6.18x	8.04x	11.9x
PEG	-	-0.2x	0.8x	-0.7x	-0.9x	7.19x	-0.9x	-3.65x
Capitalization / Revenue	44.7x	29.2x	18x	55.4x	159x	86.8x	177x	176x
EV / Revenue	38.7x	17.3x	12.4x	37.3x	117x	70.1x	147x	152x
EV / EBITDA	-28.7x	-5.12x	-6.03x	-6.9x	-13.5x	-14.8x	-14.3x	-13.9x
EV / EBIT	-28x	-5.02x	-5.9x	-6.71x	-13.2x	-14.4x	-12.3x	-11.8x
EV / FCF	-21.6x	-5.19x	-7.11x	-8.46x	-19.7x	-18x	-15.8x	-16x
FCF Yield	-4.63%	-19.3%	-14.1%	-11.8%	-5.09%	-5.54%	-6.33%	-6.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.09	-2.87	-2.52	-2.98	-3.69	-3.568	-4.361	-4.581
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	72.83	46.83	78.59	47.07	39.21	80.1	39.2	39.4
EBITDA ¹	-98.13	-158.3	-162	-254.3	-341.1	-377.9	-401	-429.4
EBIT ¹	-100.5	-161.3	-165.5	-261.6	-349.4	-389.6	-468.9	-507
Net income ¹	-100.2	-154.8	-147	-223.9	-311.4	-342.8	-436.4	-474.7
Net Debt ¹	-440.1	-559.5	-436.3	-850.9	-1,619	-1,340	-1,204	-980.5
Reference price ²	63.49	24.96	25.46	40.23	77.81	84.50	84.50	84.50
Nbr of stocks (in thousands)	51,332	54,865	55,487	64,765	79,999	82,258	-	-
Announcement Date	24/02/22	23/02/23	22/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
KYMERA THERAPEUTICS, INC.	-23.68x	70.05x	-14.85x	-.--%	6.95B
LONZA GROUP AG	28.69x	5.09x	15.79x	1.15%	42.28B
BEONE MEDICINES AG	46.16x	4.64x	29.74x	-.--%	33.87B
REVOLUTION MEDICINES, INC.	-18.9x	292.08x	-17.02x	-.--%	31.78B
IQVIA HOLDINGS INC.	20.78x	2.45x	10.6x	-.--%	28.49B
CELLTRION, INC.	31.23x	8.04x	20.64x	0.4%	27.41B
IONIS PHARMACEUTICALS, INC.	-21.31x	13.75x	-21.37x	-.--%	12.51B
EUROFINS SCIENTIFIC SE	20.58x	1.83x	8.05x	1.29%	12.2B
Average	10.44x	49.74x	3.95x	0.35%	24.43B
Weighted average by Cap.	17.62x	54.36x	8.85x	0.38%